Global mortality, prevalence and disability-adjusted life years of Alzheimer’s disease and other dementias in adults aged 60 years or older, and the impact of the COVID-19 pandemic: a comprehensive analysis for the global burden of disease 2021
Although incidence rates declined from 1990 to 2021, the overall burden of AD and dementias remains substantial and is expected to rise significantly by 2050. The findings underscore the need for targeted interventions addressing risk factors like High FPG, gender disparities, and the socioeconomic effects of COVID-19, particularly in high-SDI countries.
Authors
- Xuewen Rong (ORCID: https://orcid.org/0000-0003-3283-5347)
- Dorothy Yu
- Xu‐Guang Guo (ORCID: https://orcid.org/0000-0003-1302-5234)
- Guodong Zhu (ORCID: https://orcid.org/0000-0002-5560-0551)
- Renfu Li (ORCID: https://orcid.org/0000-0001-6841-024X)
- Jie Sun (ORCID: https://orcid.org/0000-0003-1884-1070)
Institutions
- Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality (CN)
- Guangzhou Institute of Dermatology (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1186/s12888-025-06661-2
- Citations
- 20
- Primary Topic
- Frailty in Older Adults
- Type
- article
- Field-Weighted Citation Impact
- 24.48
Funders
- University of Washington
- Institute for Health Metrics and Evaluation